Naringin

Naringin is a flavanone glycoside in which the aglycone naringenin (4',5,7-trihydroxyflavanone) is attached to the disaccharide neohesperidose (2-O-α-L-rhamnosyl-β-D-glucopyranose) via a β-1,2 glycosidic bond. This specific sugar linkage distinguishes naringin from naringenin-7-rutinoside (narirutin), which has a rutinose moiety and is far less bitter. The bitterness of naringin arises from the interaction of the neohesperidose unit with taste receptors, a property shared with other neohesperidosides such as neohesperidin.

In plants, naringin is synthesized through the phenylpropanoid pathway: naringenin is first produced from p-coumaroyl-CoA and malonyl-CoA by chalcone synthase and chalcone isomerase, then glycosylated by specific UDP-glycosyltransferases. The enzyme naringenin 7-O-glucosyltransferase and a rhamnosyltransferase sequentially add glucose and rhamnose to form the final glycoside. The pathway is regulated by environmental factors, including light and temperature, which partly explains the variability in bitterness among citrus varieties.

Naringin is most abundant in grapefruit (Citrus × paradisi) and the sour orange (Citrus aurantium), with concentrations in grapefruit juice ranging from 100 to 800 mg/L depending on cultivar, ripeness, and processing. It is also present in smaller amounts in other citrus species, such as pomelos and some mandarin hybrids. The compound is concentrated in the peel, albedo, and membranes of the fruit, which is why juicing methods that press the peel increase the bitterness of the juice.

In the human diet, naringin is ingested primarily through grapefruit juice and citrus supplements. Once consumed, it is hydrolyzed by intestinal microflora to its aglycone naringenin, which is then absorbed and metabolized. Naringin and naringenin have been studied for their potential to modulate drug-metabolizing enzymes, particularly cytochrome P450 3A4, which underlies the well-known grapefruit–drug interaction. This interaction can lead to elevated blood levels of certain medications, such as statins and calcium channel blockers, posing risks of toxicity.

Naringin exhibits a range of biological activities in experimental models, including antioxidant, anti-inflammatory, and anti-apoptotic effects. Its antioxidant capacity is attributed to its phenolic hydroxyl groups, which scavenge free radicals and chelate metal ions. In animal studies, naringin has shown protective effects against liver injury, cardiovascular disease, and diabetes, though clinical evidence in humans remains limited.

Mechanistically, naringin modulates multiple signaling pathways, including NF-κB, MAPK, and PI3K/Akt, thereby reducing inflammatory cytokine production and oxidative stress. It has also been reported to enhance bone formation by stimulating osteoblast differentiation and inhibiting osteoclast activity, suggesting a potential role in osteoporosis management. However, most studies are preclinical, and the bioavailability of naringin is low due to extensive gut metabolism, which complicates translation to therapeutic use.

Beyond its role as a bitterant, naringin is a precursor for the production of neohesperidin dihydrochalcone (NHDC), a high-intensity artificial sweetener. NHDC is derived by hydrogenating neohesperidin, which is extracted from bitter oranges, and is approved as a food additive in the European Union and several other countries. Naringin itself is also used as a bitter flavoring agent in beverages and confectionery.

Historically, naringin was first isolated in the 19th century from the flowers of the bitter orange tree, and its structure was elucidated in the 1920s by the Japanese chemist Michiyo Tsujimura, who also discovered vitamin C in green tea. In citrus taxonomy, the presence of naringin is a chemotaxonomic marker that helps distinguish species and hybrids. Additionally, naringin has been investigated for its potential to inhibit SARS-CoV-2 main protease in silico, though this remains speculative without clinical validation.

Flavanone

A type of flavonoid characterized by a saturated three-carbon chain in the C-ring, commonly found in citrus fruits.

Glycoside

A molecule in which a sugar is bound to another functional group via a glycosidic bond.

Aglycone

The non-sugar component of a glycoside, such as naringenin in naringin.

Neohesperidose

A disaccharide composed of rhamnose and glucose linked by a β-1,2 bond, responsible for the bitterness of certain flavonoids.

Cytochrome P450 3A4

An enzyme in the liver and intestine that metabolizes many drugs; inhibited by naringin and naringenin.